The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1
Abstract
Spinocerebellar ataxia type 1 (SCA1) is an autosomal dominant disorder characterized by neurodegeneration of the cerebellum, spinal cord and brainstem. A 1.2-Megabase stretch of DNA from the short arm of chromosome 6 containing the SCA1 locus was isolated in a yeast artificial chromosome contig and subcloned into cosmids. A highly polymorphic CAG repeat was identified in this region and was found to be unstable and expanded in individuals with SCA1. There is a direct correlation between the size of the (CAG)n repeat expansion and the age-of-onset of SCA1, with larger alleles occurring in juvenile cases. We also show that the repeat is present in a 10 kilobase mRNA transcript. SCA1 is therefore the fifth genetic disorder to display a mutational mechanism involving an unstable trinucleotide repeat.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“spinocerebellar ataxia type 1 (SCA1), a disease caused by a polyglutamine expansion in the protein ATAXIN1 (ATXN1).”
From Polyglutamine Disease Toxicity Is Regulated by Nemo-like Kinase in Spinocerebellar Ataxia Type 1 (2013) · cites this paper as Orr et al., 1993
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Verkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481
Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Pieretti, M., Sutcliffe, J. S., Richards, S., Verkert, A. J. M. H., Holden, J. J. A., Fenwick, R. G., Warren, S. T., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90283-5 · Cited by 2,080
Flagged first, then by citations
Research works printed but not linked: 40
- Schut, J.W. Hereditary ataxia: clinical study through six generations. Arch. Neurol. Psychiat. 63, 535–567 (1954). · DOI
- Currier, R.D., Glover, G., Jackson, J.F. & Tipton, A.C. Spinocerebellar ataxia: study of a large kindred. Neurology 22, 1040–1043 (1972). · DOI
- Nino, H.E., Noreen, H.J. & Dubey, D.P. A family with hereditary ataxia: HLA typing. Neurology 30, 12–20 (1980). · DOI
- Zoghbi, H.Y. et al. Spinocerebellar ataxia: variable age of onset and linkage to human leukocyte antigen in a large kindred. Ann. Neurol. 23, 580–584 (1988). · DOI
- Greenfield, J.G. The spino-cerebellar degenerations (Charles C. Thomas, Springfield, Illinois, 1954).
- Haines, J.L., Schut, L.J. & Weitkamp, L.R. Spinocerebellar ataxia in large kindred: age at onset, reproduction, and genetic linkage studies. Neurology 34, 1542–1548 (1984). · DOI
- Brook, J.D. et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 68, 799–808 (1992). · DOI
- Bruner, H.G. et al. Reverse mutation in myotonic dystrophy. New Engl. J. Med. 328, 476–480 (1993). · DOI
- Buxton, J. et al. Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature 355, 547–548 (1992). · DOI
- Fu, Y.-H. et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255, 1256–1259 (1992). · DOI
- Harley, H.G. et al. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature 355, 545–546 (1992). · DOI
- Harley, H.G. et al. Unstable DNA sequence in myotonic dystrophy. Lancet 339, 1125–1128 (1992). · DOI
- Kremer, E.J. et al. Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science 252, 1711–1714 (1991). · DOI
- Mahadevan, M. et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene. Science 255, 1253–1255 (1992). · DOI
- La Spada, A.R., Wilson, E.M., Lubahn, D.B., Harding, A.E. & Fishbeck, K.H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352, 77–79 (1991). · DOI
- Yakura, H., Wakisaka, A., Fujimoto, S. & Itakura, K. Hereditary ataxia and HLA genotypes. New Engl. J. Med. 291, 154–155 (1974).
- Jackson, J.F., Currier, R.D., Terasaki, P.I. & Morton, N.E. Spinocerebellar ataxia and HLA linkage: risk prediction by HLA typing. New Engl. J. Med. 296, 1138–1141 (1977). · DOI
- Ranum, L.P.W. et al. Localization of the autosomal dominant, HLA-linked spinocerebellar ataxia (SCA1) locus in two kindreds within an 8cM subregion of chromosome 6p. Am. J. hum. Genet. 49, 31–41 (1991).
- Kwiatkowski, T.J. Jr. et al. The gene for autosomal dominant spinocerebellar ataxia (SCA1) maps centromeric to D6S89 and shows no recombination, in nine large kindreds, with a dinudeotide repeat at the AM10 locus. Am. J. hum. Genet. (in the press).
- La Spada, A.R. et al. Meiotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy. Nature Genet. 2, 301–304 (1992). · DOI
- Coutinho, P. & Andrade, C. Autosomal dominant system degeneration in Portuguese families of the Azores. Neurology 28, 703–709 (1978). · DOI
- Takiyama, Y. et al. The gene for Machado-Joseph disease maps to human chromosome 14q. Nature Genet. 4, 300–304 (1993). · DOI
- Harding, A.E. Genetic aspects of autosomal dominant late onset cerebellar ataxia. J. med. Genet. 18, 436–441 (1981). · DOI
- Orozco, G. et al. Dominantly inherited olivopontocerebellar atrophy from eastern Cuba: clinical, neuropathological, and biochemical findings. J. neurol. Sci. 93, 27–50 (1989). · DOI
- Gispert, S. et al. Chromosomal assignment of the second (Cuban) locus for autosomal dominant cerebellar atrophy (SCA2) to human chromosome 12q23–24.1. Nature Genet. 4, 295–299 (1993). · DOI
- Richards, R.I. et al. Evidence of founder chromosomes in fragile X syndrome. Nature Genet. 1, 257–260 (1992). · DOI
- Harley, H.G. et al. Detection of linkage disequilibrium between the myotonic dystrophy locus and a new polymorphic DNA marker. Am. J. hum. Genet 49, 68–75 (1991).
- Quigley, C.A. et al. Complete deletion of the androgen receptor gene: definion of the null phenotype of the androgen insensitivity syndrome and determination of carrier status. J. clin. endocrinol. Metab. 74, 927–933 (1992). · DOI
- Trifiro, M. et al. The 56/58 kDa androgen-binding protein in male genital skin fibroblasts with a deleted androgen receptor gene. Molec. cell. endocrinol. 75, 37–47 (1991). · DOI
- Wharton, K.A., Johansen, K.M., Xu, T. & Artavanis-Tsakonas, S. Nucleotide sequence from the neurogenic locus notch implies a gene product that shares homology with proteins containing EGF-like repeats. Cell 43, 567–581 (1985). · DOI
- Vaessin, H. et al. prospero is expressed in neuronal precursors and encodes a nuclear protein that is involved in the control of axonal outgrowth in Drosophila. Cell 67, 941–953 (1991). · DOI
- Bellen, H.J., Kooyer, S., D'Evelyn, D. & Pearlman, J. The Drosophila Couch potato protein is expressed in nuclei of peripheral neuronal precursors and shows homology to RNA-binding proteins. Genes Dev. 6, 2125–2136 (1992). · DOI
- Courey, A.J., Holtzman, D.A., Jackson, S.P. & Tjian, R. Synergistic activation by the glutamine-rich domains of human transcription factor Sp1. Cell 59, 827–836 (1989). · DOI
- Benson, M. & Pirrotta, V. The Drosophila zeste protein binds cooperatively to sites in many gene regulatory regions: implications for transvection and gene regulation. EMBO J. 7, 3907–3915 (1988). · DOI
- Rich, S.S., Wilkie, P., Schut, L., Vance, G. & Orr, H.T. Spinocerebellar ataxia: localization of an autosomal dominant locus between two markers on human chromosome 6. Am. J. hum. Genet. 41, 524–531 (1987).
- Zoghbi, H.Y., Daiger, S.P., McCall, A., O'Brien, W.E. & Beaudet, A.L. Extensive DNA polymorphism at the factor Xllla (F13a) locus and linkage to HLA. Am. J. hum. Genet. 42, 877–883 (1988).
- Sambrook, J., Fritsch, E.F. & Maniatis, T. Molecular Cloning: A Laboratory Manual 2nd edn (Cold Spring Harbor Laboratory Press, New York, 1989).
- Weissenbach, J. et al. A second-generation linkage map of the human genome. Nature 359, 794–801 (1992). · DOI
- Albertsen, H.M. et al. Construction and characterization of a yeast artificial chromosome library containing seven haploid human genome equivalents. Proc. natn. Acad. Sci. U.S.A. 87, 4256–4260 (1990). · DOI
- Brownstein, B.H. et al. Isolation of single-copy human genes from a library of yeast artificial chromosome clones. Science 244, 1348–1351 (1989). · DOI
Cited by
Sorted by citations
Items 701–800 of 1,000
Calcium homeostasis and spinocerebellar ataxia-1 (SCA-1).
Vig, P. J., Subramony, S., & McDaniel, D. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00595-0 · Cited by 30
Huntington disease: DNA analysis in Brazilian population.
Raskin, S., Allan, N., Teive, H., Cardoso, F., Haddad, M., Levi, G., Boy, R., Lerena, J., Sotomaior, V., Janzen-Dück, M., et al. (2000) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2000000600001 · Cited by 30
Dynamic mutation loci: allele distributions in different populations
Richards, R., Crawford, J., Narahara, K., Mangelsdorf, M., Friend, K., Staples, A., Denton, M., Easteal, S., Hori, T., Kondo, I., et al. (1996) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1996.tb00437.x · Cited by 30
K�sel, S., & Graeber, M. B. (1994) · Acta Neuropathologica · doi:10.1007/bf00294355 · Cited by 70
“Over the past 2 years, the causes of several important neurological and psychiatric disorders have been clarified, including Huntington's disease [24], familial forms of Alzheimer's disease [7, 8, 11], amyotrophic lateral sclerosis [32], myotonic dystrophy [5], spinobulbar muscular atrophy [20], and spinocerebellar at…”
BackgroundNigri, A., Sarro, L., Mongelli, A., Castaldo, A., Porcu, L., Pinardi, C., Grisoli, M., Ferraro, S., Canafoglia, L., Visani, E., et al. (2021) · The Cerebellum · doi:10.1007/s12311-021-01285-0 · Cited by 31
Nakamura, N., Tsunoda, K., Mitsutake, A., Shibata, S., Mano, T., Nagashima, Y., Ishiura, H., Iwata, A., Toda, T., Tsuji, S., et al. (2020) · Investigative Ophthalmology and Visual Science · doi:10.1167/iovs.61.11.27 · Cited by 29
Collaborative Efforts for Spinocerebellar Ataxia Research in the United States: CRC-SCA and READISCA
Lin, C.-C., Ashizawa, T., & Kuo, S. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00902 · Cited by 34
“In 1993, a group of investigators led by Huda Zoghbi and Harry Orr identified a heterozygous expansion of CAG repeat that encodes a polyglutamine (polyQ) tract in a novel gene, ATXN1, in a family with an autosomal-dominant cerebellar ataxia, now known as spinocerebellar ataxia type 1 (SCA1) (4).”
BackgroundCharng, W., Yamamoto, S., & Bellen, H. J. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.03.001 · Cited by 29
Fossale, E., Seong, I. S., Coser, K. R., Shioda, T., Kohane, I. S., Wheeler, V. C., Gusella, J. F., MacDonald, M. E., & Lee, J. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr355 · Cited by 25
Identification and expression of the gene for human ataxin-2-related protein on chromosome 16.
Figueroa, K., & Pulst, S. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00287-5 · Cited by 29
Identification of alternative splicing of spinocerebellar ataxia type 2 gene.
Affaitati, A., de Cristofaro, T., Feliciello, A., & Varrone, S. (2001) · Gene · doi:10.1016/s0378-1119(01)00402-4 · Cited by 29
Molecular Mechanisms of Neurodegenerative Diseases
Chesselet, M. (2000) · Contemporary Clinical Neuroscience · doi:10.1007/978-1-59259-006-3 · Cited by 29
Hereditary Cerebellar Ataxia with Peripheral Neuropathy and Mental Retardation
Tachi, N., Kozuka, N., Ohya, K., Chiba, S., & Sasaki, K. (2000) · European Neurology · doi:10.1159/000008140 · Cited by 29
“Spinocerebellar ataxias are a genetically heterogeneous group of neurodegenerative disorders affecting the cerebellum and its connections. The mutations for SCA1 [”
BackgroundHawi, Z., Mynett-Johnson, L., Murphy, V., Straub, R., Kendler, K., Walsh, D., Mckeon, P., & Gill, M. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000560 · Cited by 29
Mouse Models of Human CAG Repeat Disorders
Burright, E. N., Orr, H. T., & Clark, H. B. (1997) · Brain Pathology · doi:10.1111/j.1750-3639.1997.tb00896.x · Cited by 28
Self-citationMachado-Joseph disease in four Chinese pedigrees
Zhou, Y., Takiyama, Y., Igarashi, S., Li, Y. F., Zhou, B. Y., Gui, D. C., Endo, K., Tanaka, H., Chen, Z. H., Zhou, L. S., et al. (1997) · Neurology · doi:10.1212/wnl.48.2.482 · Cited by 29
Forsgren, L., Libelius, R., Holmberg, M., von Döbeln, U., Wibom, R., Heijbel, J., Sandgren, O., & Holmgren, G. (1996) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)00187-6 · Cited by 23
Analysis of CAG trinucleotide expansion associated with Machado-Joseph disease.
Watanabe, M., Abe, K., Aoki, M., Kameya, T., Kaneko, J., Shoji, M., Dceda, M., Ikhizuka, M., Ikeda, Y., Iizuka, T., et al. (1996) · Journal of Neurological Sciences · doi:10.1016/0022-510x(95)00307-n · Cited by 29
Genetic Anticipation: Expanding Tandem Repeats
Carpenter, N. (1994) · Neurologic Clinics · doi:10.1016/s0733-8619(18)30071-9 · Cited by 29
Coffin, S. L., Durham, M. A., Nitschke, L., Xhako, E., Brown, A. M., Revelli, J., Gonzalez, E. V., Lin, T., Handler, H. P., Dai, Y.-W., et al. (2023) · Neuron · doi:10.1016/j.neuron.2023.02.030 · Cited by 28
“SCA1 is causedby the expansion of CAG repeats encoding thepolyglutamine (polyQ) tract inATAXIN-1 (ATXN1).(4,5)”
Self-citationKoscik, T. R., Sloat, L. M., van der Plas, E. A. A., Joers, J. M., Deelchand, D. K., Lenglet, C., Öz, G., & Nopoulos, P. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa184 · Cited by 24
“Spinocerebellar ataxia Type 1 (SCA1) is caused by polyglutamine expansion of the ataxin-1 gene (Orr et al., 1993; Banfi et al., 1994).”
BackgroundMTSS1/Src family kinase dysregulation underlies multiple inherited ataxias
Brown, A. S., Meera, P., Altindag, B., Chopra, R., Perkins, E., Paul, S., Scoles, D., Tarapore, E., Magri, J., Huang, H.-R., et al. (2018) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1816177115 · Cited by 28
“We show that MTSS1 is a target of the SCA genes ATXN1 and ATXN2 ( Fig 5I ), and that increased SFK activity from lesions in MTSS1 , SPTNB2 (SCA5), ATXN1 (SCA1), and ATXN2 (SCA2) reduces Purkinje neuron basal firing, an endophenotype that underlies multiple ataxias, providing support for the clinical use of SFK inhibit…”
InfluentialMatsuzaki, Y., Oue, M., & Hirai, H. (2013) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2013.12.004 · Cited by 32
“SCA1 was nduced through the abnormal expansion of CAG repeats in the sca1 ene (Orr et al., 1993), leading to the production of ataxin-1 proein (ATXN1) with an abnormally expanded polyglutamine tract. utant ATXN1 forms nuclear aggregates with nuclear proteins hat are critical for neuronal function,…”
BackgroundChinese patients with Huntington's disease initially presenting with spinocerebellar ataxia
Dong, Y., Sun, Y., Liu, Z. ‐., Wang, N., Shi, S., & Wu, Z. (2012) · Clinical Genetics · doi:10.1111/j.1399-0004.2012.01927.x · Cited by 28
Molecular Pathogenesis of Spinocerebellar Ataxia Type 1 Disease
Kang, S., & Hong, S. (2009) · Molecules and Cells · doi:10.1007/s10059-009-0095-y · Cited by 31
Shimizu, Y., Yoshida, K., Okano, T., Ohara, S., Hashimoto, T., Fukushima, Y., & Ikeda, S. (2004) · Journal of Human Genetics · doi:10.1007/s10038-004-0196-6 · Cited by 28
Yianni, J., Nandi, D., Bradley, K. M., Soper, N., Gregory, R., Joint, C., Stein, J., Scott, R., & Aziz, T. (2004) · Movement Disorders · doi:10.1002/mds.10716 · Cited by 28
Kovtun, I., Welch, G., Guthrie, H., Hafner, K., & McMurray, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313080200 · Cited by 28
Quinton, R., Barnett, P. S., Coskeran, P., & Bouloux, P.-M. G. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00859.x · Cited by 28
“, 1968), both result from expansions of triplet repeat sequences (La Spada et al., 1991; Orr et al., 1993).”
BackgroundBenson, K., Horwitz, M., Wolff, J., Friend, K., Thompson, E., White, S., Richards, R., Raskind, W., & Bird, T. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.11.1779 · Cited by 28
“These include Huntington disease ( 1), spinal and bulbar muscular atrophy (2), dentatorubral-pallidoluysian atrophy (3), spinocerebellar ataxias, spinocerebellar atrophy (SCA) type 1 ( 4 ), SCA2 (5‐7), SCA3 (Machado‐Joseph disease) (8), SCA6 (9) and SCA7 (10), progressive myoclonus epilepsy type 1 (11,12) and the frag…”
BackgroundMapping the Polarity of Changes That Occur in Interrupted CAG Repeat Tracts in Yeast
Maurer, D. J., O'Callaghan, B. L., & Livingston, D. M. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.8.4597 · Cited by 28
Spinocerebellar ataxia type 1 in Russia
Illarioshkin, S., Slominsky, P. A., Ovchinnikov, I., Markova, E., Miklina, N., Klyushnikov, S. A., Shadrina, M., Vereshchagin, N., Limborskaya, S., & Ivanova-Smolenskaya, I. (1996) · Journal of Neurology · doi:10.1007/bf00886871 · Cited by 28
Genetic mapping of the spinocerebellar ataxia type 2 gene on human chromosome 12
Nechiporuk, A., Lopes-Cendes, Í., Nechiporuk, T., Starkman, S., Andermann, E., Rouleau, G., Weissenbach, J., Kort, E., & Pulst, S. M. (1996) · Neurology · doi:10.1212/wnl.46.6.1731 · Cited by 28
Sasaki, H., Wakisaka, A., Fukazawa, T., Iwabuchi, K., Hamada, T., Takada, A., Mukai, E., Matsuura, T., Yoshiki, T., & Tashiro, K. (1995) · Journal of Neurological Sciences · doi:10.1016/0022-510x(95)00175-2 · Cited by 28
DNA analysis in forensics, disease and animal/plant identification.
Alford, R., & Caskey, C. (1994) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(05)80066-7 · Cited by 28
The fragile X syndrome: implications of molecular genetics for the clinical syndrome
Rousseau, F. (1994) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1994.tb02052.x · Cited by 28
Cognitive repercussions of hereditary cerebellar disorders.
Manto, M., & Lorivel, T. (2011) · Cortex; a journal devoted to the study of the nervous system and behavior · doi:10.1016/j.cortex.2009.04.012 · Cited by 28
Expanded Repeat Sequences and Disease
Lindblad, K., & Schalling, M. (1999) · Seminars in neurology · doi:10.1055/s-2008-1040845 · Cited by 28
Chopra, R., Bushart, D. D., Cooper, J.-P. R., Yellajoshyula, D., Morrison, L. M., Huang, H.-R., Handler, H. P., Man, L.-K. J., Dansithong, W., Scoles, D., et al. (2020) · bioRxiv · doi:10.1093/hmg/ddaa212 · Cited by 27
“Spinocerebellar ataxia type 1 (SCA1) is a polyglutamine disorder caused by CAG repeat expansion within the Ataxin-1 (ATXN1) gene (3).”
BackgroundSelf-citationA cell-based screen for modulators of ataxin-1 phosphorylation.
Kaytor, M., Byam, C. E., Tousey, S. K., Stevens, S., Zoghbi, H., & Orr, H. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi122 · Cited by 27
“Spinocerebellar ataxia type 1 (SCA1) is an autosomal dominant adult onset neurological disorder caused by the expansion of a CAG repeat encoding a polyglutamine tract within ataxin-1 (1) and, thus, belongs to a group of neurodegenerative disorders known as the polyglutamine diseases.”
BackgroundSelf-citationEarly onset autosomal dominant dementia with ataxia, extrapyramidal features, and epilepsy
Filla, A., Michele, G. D., Cocozza, S., Patrignani, A., Volpe, G., Castaldo, I., Ruggiero, G., Bonavita, V., Masters, C. L., Casari, G., et al. (2002) · Neurology · doi:10.1212/wnl.58.6.922 · Cited by 26
High prevalence of spinocerebellar ataxia type 1 (SCA1) in an isolated region of Japan.
Onodera, Y., Aoki, M., Tsuda, T., Kato, H., Nagata, T., Kameya, T., Abe, K., & Itoyama, Y. (2000) · Journal of Neurological Sciences · doi:10.1016/s0022-510x(00)00390-7 · Cited by 27
Chronic inflammatory demyelinating polyneuropathy during treatment with interferon-α
Marzo, M. E., Tintoré, M., Fábregues, O., Montalban, X., & Codina, A. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.65.4.604 · Cited by 27
Origins and evolution of huntington disease chromosomes
Andrew, S. E., & Hayden, M. R. (1995) · Neurodegeneration · doi:10.1016/1055-8330(95)90013-6 · Cited by 26
IT15 gene expression in fetal human brain
Dure, L. S., Landwehrmeyer, G. B., Golden, J. A., McNeil, S. M., Ge, P., Aizawa, H., Huang, Q., Ambrose, C. M., Duyao, M. P., Bird, E. D., et al. (1994) · Brain Research · doi:10.1016/0006-8993(94)90860-5 · Cited by 26
DGGE screening of PKD1 gene reveals novel mutations in a large cohort of 146 unrelated patients
Perrichot, R., Mercier, B., Simon, P., Whebe, B., Clèdes, J., & Férec, C. (1999) · Human Genetics · doi:10.1007/s004399900122 · Cited by 27
Behn-Krappa, A., & Doerfler, W. (1994) · Human Mutation · doi:10.1002/humu.1380030104 · Cited by 30
Therapeutic antisense oligonucleotides for movement disorders
Doxakis, E. (2020) · Medicinal Research Reviews · doi:10.1002/med.21706 · Cited by 34
“Normal alleles have 6–39 repeats, while pathological repeats have 39–91 repeats.(233,234) ATXN1 has a nuclear localization signal (NLS) and its wild‐”
BackgroundStructural signature in SCA1: clinical correlates, determinants and natural history
Martins, C. R., Martinez, A. R. M., Faber, I., de Rezende, T. J. R., Casseb, R. F., Pedroso, J. L., Barsottini, O. G. P., Lopes‐Cendes, Í., & França, M. C. (2018) · Journal of Neurology · doi:10.1007/s00415-018-9087-1 · Cited by 24
Buijsen, R. A. M., Gardiner, S., Bouma, M., van der Graaf, L. M., Boogaard, M., Pepers, B., Eussen, B., de Klein, A., Freund, C., & van Roon-Mom, W. V. (2018) · Stem Cell Research · doi:10.1016/j.scr.2018.03.018 · Cited by 26
“SCA1 is caused by a CAG triplet repeat expansion in exon 8 of the ATXN1 gene located on chromosome 6p22-p23 (Orr et al., 1993).”
BackgroundFrom gene to therapy in spinal and bulbar muscular atrophy: Are we there yet?
Pennuto, M., & Rinaldi, C. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.07.005 · Cited by 26
“…the coding regions of the genes coding for huntingtin (Macdonald et al., 1993), atrophin-1 (Koide et al., 1994; Nagafuchi et al., 1994), ataxin-1 (Orr et al., 1993), ataxin-2 (Imbert et al., 1996), ataxin-3 (Kawaguchi et al., 1994), CACNA1A (Zhuchenko et al., 1997), ataxin-7 (David et al.,…”
Gardiner, S. L., van Belzen, M. J., Boogaard, M. W., van Roon‐Mom, W., Rozing, M. P., van Hemert, A. M., Smit, J. H., Beekman, A. T. F., van Grootheest, G., Schoevers, R. A., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.116 · Cited by 28
mRNA metabolism and neuronal disease
Linder, B., Fischer, U., & Gehring, N. H. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.04.052 · Cited by 28
“in RNA-binding proteins [15] as well as toxic RNA trinucleotide repeat expansions [16,17], Fragile X Syndrome (FXS), which is caused by mutations in the FMR1 gene that encodes a key regulator of neuronal mRNA translation [18], and spinocerebellar ataxia which is also often caused by trinucleotide repeat expansions [19…”
BackgroundUbcH6 interacts with and ubiquitinates the SCA1 gene product ataxin-1.
Hong, S.-H., Lee, S., Cho, S.-G., & Kang, S. (2008) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2008.04.066 · Cited by 26
Stem cells and neurodegenerative diseases
Hou, L., & Hong, T. (2008) · Science in China Series C Life Sciences · doi:10.1007/s11427-008-0049-1 · Cited by 26
Li, M.-S., Ishikawa, K., Toru, S., Tomimitsu, H., Takashima, M., Goto, J., Takiyama, Y., Sasaki, H., Imoto, I., Inazawa, J., et al. (2003) · Journal of Human Genetics · doi:10.1007/s100380300017 · Cited by 26
“4 (Herman-Bert et al. 2000), SCA14 on 19q13.”
BackgroundInfluentialChataway, J., Sawcer, S. J., Coraddu, F., Feakes, R. W., Broadley, S., Jones, H. B., Clayton, D. G., Gray, J., Goodfellow, P. N., & Compston, A. (1999) · Neurogenetics · doi:10.1007/s100480050058 · Cited by 28
Mitotic and meiotic instability of the CAG trinucleotide repeat in spinocerebellar ataxia type 1
Koefoed, P., Hasholt, L., Fenger, K., Nielsen, J., Eiberg, H., Buschard, K., & Sørensen, S. A. (1998) · Human Genetics · doi:10.1007/s004390050870 · Cited by 26
“The number of CAG repeat units in the normal alleles are 6–39 while the disease-causing alleles contain 39–81 CAG repeats (Matilla et al. 1993; Orr et al. 1993; Goldfarb et al. 1996).”
BackgroundInfluentialRamesar, R., Bardien, S., Beighton, P., & Bryer, A. (1997) · Human Genetics · doi:10.1007/s004390050478 · Cited by 26
Matsumura, R., Takayanagi, T., Fujimoto, Y., Murata, K., Mano, Y., Horikawa, H., & Chuma, T. (1996) · Journal of Neurological Sciences · doi:10.1016/0022-510x(96)00016-0 · Cited by 26
Machado-Joseph disease in east Arnhem Land, Australia
Burt, T., Currie, B. J., Kilburn, C., Lethlean, A., Dempsey, K., Blair, I. P., Cohen, A., & Nicholson, G. (1996) · Neurology · doi:10.1212/wnl.46.4.1118 · Cited by 26
Absence of postoperative hyponatremia syndrome in young, healthy females
Wijdicks, E., & Larson, T. (1994) · Annals of Neurology · doi:10.1002/ana.410350520 · Cited by 26
8 Androgen insensitivity syndrome
Patterson, M., Mcphaul, M., & Hughes, I. (1994) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80258-7 · Cited by 26
Huntington's disease: testing the test
Read, A. (1993) · Nature Genetics · doi:10.1038/ng0893-329 · Cited by 26
Mechanical stress and formation of protein aggregates in neurodegenerative disorders
Hachiya, N., Kozuka, Y., & Kaneko, K. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2007.06.043 · Cited by 24
Ito, Y., Tanaka, F., Yamamoto, M., Doyu, M., Nagamatsu, M., Riku, S., Mitsuma, T., & Sobue, G. (2004) · Neurochemical Research · doi:10.1023/a:1022441101801 · Cited by 26
“Huntington disease (HD) (1,2), spinal and bulbar muscular atrophy (SBMA) (3-7), spinocerebellar ataxia type 1 (SCA1) ( 8 ), dentatorubral-pallidoluysian atrophy (DRPLA) (9-11), Machado-Joseph disease (MJD) (12-”
BackgroundUncovering Essential Tremor Genetics: The Promise of Long-Read Sequencing
Marsili, L., Duque, K. R., Bode, R. L., Kauffman, M., & Espay, A. J. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.821189 · Cited by 29
“The Example of Spinocerebellar Ataxia Type 10 Spinocerebellar ataxias (SCAs) are a heterogeneous group of conditions associated with ataxia (19).”
BackgroundGenome-wide detection of short tandem repeat expansions by long-read sequencing
Liu, Q., Tong, Y., & Wang, K. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-03876-w · Cited by 26
PolyQ Tract Toxicity in SCA1 is Length Dependent in the Absence of CAG Repeat Interruption
Nethisinghe, S., Pigazzini, M. L., Pemble, S. E., Sweeney, M. G., Labrum, R. W., Manso, K., Moore, D., Warner, J. P., Davis, M. B., & Giunti, P. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00200 · Cited by 28
“There is an inverse correlation between the CAG repeat length and the age at disease onset that is dramatically improved if one takes into account the longest contiguous CAG repeat stretch in the expanded allele (Orr et al., 1993; Jodice et al., 1994).”
BackgroundForman, O. P., Risio, L. D., Matiasek, K., Platt, S. R., & Mellersh, C. S. (2014) · Mammalian Genome · doi:10.1007/s00335-014-9547-6 · Cited by 40
“Polyglutamine expansions are associated with several SCA types in humans including SCA1, 2, 3, 6, 7 and 17 (Higgins et al. 1996; Koide et al. 1999; Lindblad et al. 1996; Orr et al. 1993; Riess et al. 1997; Sanpei et al. 1996).”
BackgroundLee, D. Y., Xun, Z.-Y., Platt, V. M., Budworth, H., Canaria, C., & McMurray, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068831 · Cited by 25
“ECAR doubled in the STR, HIP, and CTX (Figure 1E,F), and increased approximately 60% in the CBL (Figure 1E,F).”
BackgroundInfluentialChang, K., Chen, W.-L., Lee, L.-C., Lin, C., Kung, P., Lin, T., Wu, Y.-C., Wu, Y., Chen, Y., Lee‐Chen, G., et al. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/471659 · Cited by 26
“Among them, the expansions of CAG trinucleotide repeats encoding a polyglutamine (polyQ) stretch have been shown to cause dominantly inherited SCA1, SCA2, SCA3, SCA6, SCA7, SCA17, and dentatorubropallidoluysianatrophy (DRPLA) [2–8].”
BackgroundSuzuki, K., Zhou, J., Sato, T., Takao, K., Miyagawa, T., Oyake, M., Yamada, M., Takahashi, H., Takahashi, Y., Goto, J., et al. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.01.014 · Cited by 28
Therapeutic gene silencing in neurological disorders, using interfering RNA
Ralph, G. S., Mazarakis, N. D., & Azzouz, M. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0649-1 · Cited by 28
“Spinocerebellar ataxia type 1 (SCA1) is an autosomal dominant, progressive neurodegenerative disease caused by a polyQ expansion in the ataxin-1 protein, leading to a loss of motor coordination primarily through the death of cerebellar Purkinje cells [59].”
BackgroundHecimovic, S., Klepac, N., Vlašić, J., Vojta, A., Janko, D., Škarpa-Prpić, I., Canki‐Klain, N., Marković, D., Bozikov, J., Relja, M., et al. (2002) · Human Mutation · doi:10.1002/humu.9055 · Cited by 25
“In addition, loss of triplets, other than CAG, within the CAG repeat region could make this sequence more unstable and liable to expansion, as was previously found in fragile X syndrome and spinocerebellar ataxia type 1 (Orr et al., 1993).”
BackgroundSchelhaas, H., Ippel, P., Beemer, F., & Hageman, G. (2000) · European Journal of Neurology · doi:10.1046/j.1468-1331.2000.00067.x · Cited by 25
“Spinocerebellar ataxia 1, 2, 3, 6 and 7 are caused by an expanded CAG repeat (Table 3; Orr et al., 1993; Kawaguchi et al., 1994; Imbert et al., 1996; Pulst et al., 1996; Zhuchenko et al., 1997).”
BackgroundRecent advances in heritable ataxias
Hurko, O. (1997) · Annals of Neurology · doi:10.1002/ana.410410103 · Cited by 25
Relationship of (CAG)nC configuration to repeat instability of the Machado-Joseph disease gene
Matsumura, R., Takayanagi, T., Murata, K., Futamura, N., Hirano, M., & Ueno, S. (1996) · Human Genetics · doi:10.1007/s004390050276 · Cited by 25
Vig, P. J., Lopez, M. E., Wei, J.-R., D'Souza, D., Subramony, S., Henegar, J., & Fratkin, J. (2006) · Journal of Neurological Sciences · doi:10.1901/jaba.2006.23-166 · Cited by 25
Chen, Z., Morris, H. R., Polke, J. M., Wood, N. W., Gandhi, S., Ryten, M., Houlden, H., & Tucci, A. (2024) · Practical Neurology · doi:10.1136/pn-2023-003938 · Cited by 36
“On examination, he demonstrates dysarthric speech, nystagmus, asymmetric bradykinesia with an intermittent rest tremor, peripheral neuropathy, appendicular dysmetria, and an ataxic gait.”
Marchianò, F., Haering, M., & Habermann, B. H. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac306 · Cited by 29
“SCA1 affects the cerebellum as well as the inferior olive and is caused by polyglutamine expansion in the ATAXIN1 gene, which encodes a transcriptional regulator (33).”
BackgroundMolecular Mechanisms in Pentanucleotide Repeat Diseases
Loureiro, J. R., Castro, A. F., Figueiredo, A. S., & Silveira, I. (2022) · Cells · doi:10.3390/cells11020205 · Cited by 28
“In preclinical studies, non-allele specific ASOs acting by RNase-H degradation have been successful for SCA1 [171], SCA3 [173,174], SCA7 [177] and DM1 [178].”
InfluentialVariable number tandem repeats – Their emerging role in sickness and health
Marshall, J. N. G., Lopez, A. I., Pfaff, A. L., Kõks, S., Quinn, J. P., & Bubb, V. J. (2021) · Experimental Biology and Medicine · doi:10.1177/15353702211003511 · Cited by 29
Park, J. Y., Joo, K., & Woo, S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00892 · Cited by 24
Trinucleotide Repeat Expansion Diseases, RNAi, and Cancer
Murmann, A. E., Yu, J., Opal, P., & Peter, M. E. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.08.004 · Cited by 25
“They include SCA1 [6], SCA2 [7], SCA3 [8], SCA6 [9], SCA7 [10], SCA12 [11], and SCA17 [12].”
BackgroundMolecular dynamics analysis of the aggregation propensity of polyglutamine segments
Wen, J., Scoles, D., & Facelli, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178333 · Cited by 24
Mutant Ataxin-1 Inhibits Neural Progenitor Cell Proliferation in SCA1
Cvetanović, M., Hu, Y.-S., & Opal, P. (2016) · The Cerebellum · doi:10.1007/s12311-016-0794-9 · Cited by 23
“We decided to focus on VEGF because we have recently shown that ATXN1 acting within neurons directly inhibits VEGF transcription leading to a decrease in VEGF levels in the cerebella of Atxn1 154Q/2Q mice.”
InfluentialLANP mediates neuritic pathology in Spinocerebellar ataxia type 1
Cvetanović, M., Kular, R. K., & Opal, P. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.07.024 · Cited by 23
“Its genetic basis lies in a CAG trinucleotide repeat expansion in the coding region of the ATXN1 gene, that in turn results in a glutamine-repeat expansion in the protein ataxin-1 (ATXN1) (Opal and Zoghbi, 2002; Orr et al., 1993).”
BackgroundOphthalmologic features of the common spinocerebellar ataxias
Pula, J., Gomez, C. M., & Kattah, J. (2010) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e32833eaf71 · Cited by 24
Longitudinal cerebral blood flow changes during speech in hereditary ataxia
Sidtis, J. J., Strother, S. C., Naoum, A., Rottenberg, D. A., & Gomez, C. M. (2010) · Brain and Language · doi:10.1016/j.bandl.2010.03.007 · Cited by 22
“…cerebral glucose metabolism was studied as a function of disease stage in seven affected and seven individuals at risk for developing hereditary ataxia (Matthew et al. 1993) from a kindred subsequently identified as carrying the spino-cerebellar ataxia type 1 (SCA1) mutation (Orr et al. 1993).”
BackgroundKikuchi, A., Takeda, A., Fujihara, K., Kimpara, T., Shiga, Y., Tanji, H., Nagai, M., Ichinose, H., Urano, F., Okamura, N., et al. (2004) · Movement Disorders · doi:10.1002/mds.10712 · Cited by 24
Instability at sequence repeats in melanocytic tumours
Richetta, A., Ottini, L., Falchetti, M., Innocenzi, D., Bottoni, U., Faiola, R., Mariani-Costantini, R., & Calvieri, S. (2001) · Melanoma research · doi:10.1097/00008390-200106000-00010 · Cited by 24
Zhou, Y.-X., Qiao, W., Gu, W.-H., Xie, H., Tang, B.-S., Zhou, L., Yang, B., Takiyama, Y., Tsuji, S., He, H.-Y., et al. (2001) · Archives of Neurology · doi:10.1001/archneur.58.5.789 · Cited by 24
“The SCA1 gene was subsequently cloned and the mutation identified as an unstable trinucleotide CAG repeat.(17) This study was part of a larger effort to characterize 75 Chinese families diagnosed as having autosomal dominant SCA.”
BackgroundGilman, S. (2000) · Clinical neuropharmacology · doi:10.1097/00002826-200011000-00002 · Cited by 24
“Currently, the classification includes: Spinocerebellar Ataxia (SCA) Type 1, which has a locus on chromosome 6p22–p23 (1,2); SCA2 on 12q23–q24.”
BackgroundPolyglutamine-mediated aggregation and cell death.
de Cristofaro, T., Affaitati, A., Feliciello, A., Avvedimento, E., & Varrone, S. (2000) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1006/bbrc.2000.2843 · Cited by 24
Structural basis for triplet repeat disorders: a computational analysis
Baldi, P., Brunak, S., Chauvin, Y., & Pedersen, A. (1999) · Bioinform. · doi:10.1093/bioinformatics/15.11.918 · Cited by 24
“Huntington’s disease, DRPLA, Kennedy’s disease and spinocerebellar ataxias 1, 2, 3, 6 and 7 are all associated with expanded CAG triplets in coding regions (Spada et al., 1991; Huntington’s Disease Collaborative Research Group, 1993; Orr et al., 1993; Koide et al., 1994; Nagafuchi et al., 1994; Brooks and Fischbeck, 1…”
BackgroundInfluentialLens epithelial changes and mutated gene expression in patients with myotonic dystrophy
Abe, T., Sato, M., Kuboki, J., Kano, T., & Tamai, M. (1999) · British Journal of Ophthalmology · doi:10.1136/bjo.83.4.452 · Cited by 24
“Several genetic conditions caused by trinucleotide repeat expansion have been documented and some showing anticipation have been reported in several neurological disorders.”
BackgroundMastaglia, F., Harker, N., Phillips, B. A., Day, T., Hankey, G., Laing, N., Fabian, V., & Kakulas, B. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.4.543 · Cited by 24
“In addition to the myotonic dystrophy CTG repeat, the two SCN4A microsatellites, and the TCRB microsatellite, nine other microsatellite markers (the spinocerebellar ataxia one SCA1”
BackgroundHereditary Ataxia with Sensory Neuronopathy
Nachmanoff, D. B., Segal, R., Dawson, D., Brown, R. B., & de Girolami, U. (1997) · Neurology · doi:10.1212/wnl.48.1.273 · Cited by 24
Ishikawa, K., Mizusawa, H., Saito, M., Tanaka, H., Nakajima, N., Kondo, N., Kanazawa, I., Shoji, S., & Tsuji, S. (1996) · Brain : a journal of neurology · doi:10.1093/brain/119.4.1173 · Cited by 24
“Among these, spinocerebellar ataxia type 1 and MJD have been both demonstrated to be associated with the © Oxford University Press 1996 expansion of the unstable trinucleotide CAG repeats (Orr et al., 1993; Kawaguchi et al., 1994).”
Background
Metadata
- Authors
- Orr, H. T., Chung, M.-Y., Banfi, S., Kwiatkowski, T. J., Servadio, A., Beaudet, A. L., McCall, A. E., Duvick, L. A., Ranum, L. P. W., & Zoghbi, H. Y.
- Affiliations
- University of Minnesota (US)
- Baylor College of Medicine (US)
- Howard Hughes Medical Institute (US)
- ORCID
- Venue
- Nature Genetics
- Published
- 1993-07
- Volume
- 4
- Issue
- 3
- Pages
- 221-226
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2255469197
- Cited by
- 1,632
- References
- 0
- Citations by year
- 2026: 20 · 2025: 24 · 2024: 30 · 2023: 37 · 2022: 45 · 2021: 35 · 2020: 41 · 2019: 27 · 2018: 42 · 2017: 35 · 2016: 23 · 2015: 19 · 2014: 41 · 2013: 50 · 2012: 34
- FWCI
- 40.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- spinocerebellar ataxia type 1, CAG repeat expansion, trinucleotide repeat instability, age of onset, chromosome 6, repeat polymorphism, mRNA transcripts, neurodegeneration
- MeSH terms
- Base Sequence, Chromosome Mapping, Chromosomes, Human, Pair 6, Cloning, Molecular, DNA, Female, Humans, Male, Molecular Sequence Data, Oligodeoxyribonucleotides, Pedigree, Repetitive Sequences, Nucleic Acid, Spinocerebellar Degenerations, Transcription, Genetic, Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review